Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of...

por Burade V, Zalawadia R, Patel A, Ogundele A
Publicado 2020

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy

por Jordão MLS, Hatanaka M, Ogundele A, Moraes Silva MR, Vessani RM
Publicado 2014

The Prevalence and Incidence of Dry Eye Disease Among Patients Using Continuous Positive Airway Pressure or Other Nasal Mask Therapy Devices to Treat Sleep Apnea

por Matossian C, Song X, Chopra I, Sainski-Nguyen A, Ogundele A
Publicado 2020

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

por Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Publicado 2021

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

por White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Publicado 2020

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease

por White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Publicado 2020

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical...

por Labetoulle M, Schmickler S, Galarreta D, Böhringer D, Ogundele A, Guillon M, Baudouin C
Publicado 2018

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

por White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM
Publicado 2019